Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
0.0%
operating margin TTM
0.0%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -12.76 |
| peg ratio | 0.90 |
| price to book ratio | 4.00 |
| price to sales ratio | 0.00 |
| enterprise value multiple | -20.73 |
| price fair value | 4.00 |
profitability ratios | |
|---|---|
| gross profit margin | 0.0% |
| operating profit margin | 0.0% |
| pretax profit margin | 0.0% |
| net profit margin | 0.0% |
| return on assets | -28.08% |
| return on equity | -101.24% |
| return on capital employed | -31.62% |
liquidity ratios | |
|---|---|
| current ratio | 10.01 |
| quick ratio | 10.01 |
| cash ratio | 9.29 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.01 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -22.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.64 |
| cash per share | 2.62 |
| operating cash flow per share | -0.63 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -22.30 |
| short term coverage ratios | -171.74 |
| capital expenditure coverage ratio | -32.65 |
Frequently Asked Questions
When was the last time Immix Biopharma, Inc. (NASDAQ:IMMX) reported earnings?
Immix Biopharma, Inc. (IMMX) published its most recent earnings results on 07-11-2025.
What is Immix Biopharma, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Immix Biopharma, Inc. (NASDAQ:IMMX)'s trailing twelve months ROE is -101.24%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Immix Biopharma, Inc. (IMMX) currently has a ROA of -28.08%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMMX's net profit margin stand at?
IMMX reported a profit margin of 0.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMMX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.01 in the most recent quarter. The quick ratio stood at 10.01, with a Debt/Eq ratio of 0.01.